- 
                                    
                                    A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 - A GLURP-MSP3 fusion protein malaria vaccine candidate
 - 
                                    
                                    Immunological responses against Plasmodium falciparum Apical Membrane Antigen 1 vaccines vary depending on the population immunized
 
- 課程介紹
 - 課程安排
 - 評論
 
登入
忘記密碼